Should We Look for Anti-Rna Polymerase III Antibodies in Systemic Sclerosis Patients With Anti-Centromere or Anti-Topoisomerase I Antibodies?

European Journal of Internal Medicine - Netherlands
doi 10.1016/j.ejim.2017.07.033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Molecular Subtypes of Systemic Sclerosis in Association With Anti-Centromere Antibodies and Digital Ulcers

Genes and Immunity
ImmunologyGenetics
2009English

Detecting Gastrointestinal Manifestations in Patients With Systemic Sclerosis Using Anti-gAChR Antibodies

Arthritis Research & Therapy
2020English

Abnormalities of T Lymphocyte Subsets in Systemic Sclerosis Demonstrated With Anti-Cd45ra and Anti-Cd29 Monoclonal Antibodies.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1991English

Elevation of IgG Levels Is a Serological Indicator for Pulmonary Fibrosis in Systemic Sclerosis With Anti-Topoisomerase I Antibodies and Those With Anticentromere Antibody

Clinical and Experimental Dermatology
Dermatology
2008English

Diagnostic Value of Anti-Topoisomerase I Antibodies in a Large Monocentric Cohort

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2009English

Anti-Thyroid Peroxidase and Anti-Thyroglobulin Antibodies in Patients With Hypothyroidism

Journal of Medical Science And clinical Research
2016English

Anti-Thyroid Antibodies in Patients With Hyperprolactinemia.

Endocrinologia Japonica
1991English

Increased Intrathecal High-Avidity Anti-Tau Antibodies in Patients With Multiple Sclerosis

PLoS ONE
Multidisciplinary
2011English

Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy